Drugwatch FAQ

Our Drugwatch FAQ provides quick answers to some of the most common questions about our company. Learn about who we help, how long we’ve been in business and our business partners.

Pages in this Section:

What is Drugwatch’s Mission?

To keep people safe from potentially harmful drugs, medical devices and procedures by informing them of medical conditions, severe side effects and ways to take action.

What Services Does Drugwatch Offer?

Drugwatch offers trustworthy information on the risks of certain prescription drugs and medical devices. If people need legal help, we connect them with experienced drug and device lawyers from national law firms.

We also assist journalists, media and researchers by giving them the whole picture on a potentially dangerous drug or medical device. We can also provide the stories of people harmed by drugs and devices. Our in-house expert writers and researchers are available for interviews.

Where Is Drugwatch Located?

1 South Orange Ave,
Suite 201
Orlando, FL 32801

When Was Drugwatch Founded?

In 2009.

How Do I Get in Touch With Drugwatch?

Drugwatch’s main email is information@drugwatch.com. We check this inbox regularly. Once we receive your email, one of our writers will respond to you in about two to three business days. You may also email one of our writers directly through their respective Drugwatch email addresses.

You may write to the website or any of our writers at this address:

1 South Orange Ave, Suite 201
Orlando, FL 32801

Is Drugwatch a Law Firm?

Drugwatch is not a law firm and the people here cannot give legal advice. But, people can sign up for a free case review on the site and speak to experienced drug and device lawyers from recognized national law firms.

How Is Drugwatch Funded?

Drugwatch does not charge for services or receive money from advertising. Instead, Wilson and Peterson, LLP — a Washington D.C.-based, mass-torts law firm — sponsors the website and pays the operating costs.

What Is The Wilson and Peterson, LLP

Wilson and Peterson, LLP is Drugwatch’s sponsor. Brian Wilson — who is licensed to practice law in Washington, D.C. and Florida — oversees the firm’s operations and has spent more than a decade leading clients through challenging legal matters.

While the firm sponsors Drugwatch, there is no requirement to be a client of Wilson and Peterson, LLP to utilize Drugwatch’s services.

Who Works for Drugwatch?

Drugwatch’s staff is made up of writers, outreach professionals and website designers. The site’s writers come from various professional backgrounds including newspapers, TV, magazines and universities. The designers work together with the writers to deliver information that is comprehensive and easy to understand. The outreach team makes connections with likeminded professionals to spread awareness about potentially dangerous drugs and medical devices.

Can Drugwatch Give Medical Advice?

Drugwatch does not employ doctors or licensed medical professionals, so it does not provide medical advice. Nothing presented on Drugwatch is a substitute for the advice of a doctor or other licensed health care provider.

How Does Drugwatch Connect People with Lawyers?

People injured by one of the drugs or devices mentioned on Drugwatch can sign up for a free case review on the site. For faster service, they can also call the phone number listed on the page of the drug or medical device in question.

Drugwatch never spams any of our site visitors or engages in predatory practices to sign people up for lawsuits. If site visitors do not wish to sign up for a lawsuit, they can still use all the information on Drugwatch.

Does it Cost Anything to Get a Case Review Through Drugwatch?

No. Case reviews and use of the website are free to site visitors.

What Happens After I Sign Up for a Free Case Review?

After someone signs up for a free case review with Drugwatch, one of the legal partners will contact them. They will ask a few more questions about injuries and the drug or medical device. The firm’s representatives will let the person know if they are able to represent them.

The firm will then send out a retainer, a legal contract to represent the potential client. Until the contract is signed and returned, the firm cannot act on the client’s behalf.

At this point, the firm does not share any information with Drugwatch and our staff has no access to information pertaining to a particular case. For status updates, always contact the law firm directly.

Where Does Drugwatch Get Information?

Drugwatch gets its information from peer-reviewed medical journals, trusted news outlets, expert interviews and government reports.

Does Drugwatch Provide Interviews?

Yes, our writers are available for interviews, podcasts and email commentary.

What is Drugwatch’s Privacy Policy?

Drugwatch is committed to protecting your privacy. In order to use Drugwatch’s services, visitors voluntarily supply the information requested on the site such as name, address, telephone number and email address. This information is only used to provide you with the service you requested, such as a free case review.

Although we may use your email address to send you news or contact you about Drugwatch services, the site will not share any personal information with a third party unless the visitor authorizes it. For more detailed information, please review Drugwatch’s privacy policy.

What Happens When I Share My Story with Drugwatch?

Anything shared with Drugwatch is private. If the site would like to publish a story on the website to help others understand the dangers of a drug or medical device, a writer will ask permission to do so. On some occasions, our writers will also ask if someone who shared their story with Drugwatch would be willing to speak to professional journalists.

Can I Contact a Drugwatch Writer?

Yes. All of the pages and news posts on the site are attributed to a writer. Anyone can contact a writer through email links on these pages or through email links on his or her individual bio page.

Please seek the advice of a medical professional before making health care decisions.


Kevin Connolly joined Drugwatch as managing editor after 20 years in newspapers, mainly the Orlando Sentinel. He is a watchdog at Drugwatch, where pharmaceutical companies hawking dangerous drugs and device manufacturers selling defective medical products are held accountable. He is a member of the International Society for Medical Publication Professionals, the Drug Information Association, the American Association for the Advancement of Science, Physicians for Responsible Opioid Prescribing and Investigative Reporters and Editors.